SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 149 | 1 | 142 | −6 |
| Shares | 66.3M | 38.2K | 69.6M | +3.40M (+5.1%) |
| Value | $1.70B | $982.2K | $1.82B | +$120.8M (+7.1%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 130,000 | $3.41M | 1.34% |
| Walleye Capital LLC | 48,613 | $1.27M | 0.02% |
| Qube Research & Technologies Ltd | 22,549 | $591.2K | 0.00% |
| Tudor Investment Corp Et Al | 21,197 | $555.8K | 0.01% |
| Oppenheimer Asset Management Inc. | 11,688 | $306.5K | 0.00% |
| Sanders Morris Harris LLC | 11,200 | $295.1K | 0.07% |
| Innovis Asset Management LLC | 8,613 | $225.8K | 0.08% |
| Snowden Capital Advisors LLC | 7,898 | $207.1K | 0.01% |
| Exchange Traded Concepts, LLC | 4,972 | $130.4K | 0.00% |
| Group One Trading, L.P. | 1,316 | $34.5K | 0.00% |
| Glassman Wealth Services | 12 | $315 | 0.00% |
| Harbour Investments, Inc. | 10 | $262 | 0.00% |
| Comerica Bank | 4,562 | $85 | 0.01% |
Sold out (19)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Victory Capital Management Inc | 516,352 | $13.3M |
| Millennium Management LLC | 149,655 | $3.85M |
| Nomura Holdings Inc | 70,521 | $1.82M |
| Twinbeech Capital LP | 56,658 | $1.46M |
| Trexquant Investment LP | 49,843 | $1.28M |
| Oracle Investment Management Inc | 43,500 | $1.12M |
| Dynamic Technology Lab Private Ltd | 21,650 | $557.0K |
| Algert Global LLC | 19,184 | $493.8K |
| HRT Financial LP | 16,558 | $426.0K |
| Cubist Systematic Strategies, LLC | 15,387 | $396.1K |
| Jump Financial, LLC | 12,900 | $332.0K |
| Dark Forest Capital Management LP | 8,910 | $229.3K |
| Centiva Capital, LP | 8,484 | $218.4K |
| American Century Companies Inc | 10,709 | $163.7K |
| Belpointe Asset Management LLC | 3,068 | $79.0K |
| Allspring Global Investments Holdings, LLC | 1,128 | $29.0K |
| Aquatic Capital Management LLC | 200 | $5.00K |
| Pinnacle Bancorp, Inc. | 102 | $2.63K |
| Ellevest, Inc. | 8 | $206 |
Not filed for Q2 2023 yet (1)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Kula Investments, LLC | 38,159 | $982.2K |